-Dennis W Dickson Researcher Activity Profile

Research Author Detailed Information 

Dennis W Dickson Publication Rate By Year

Dennis W Dickson has published 1 paper(s) in 1988, 2 paper(s) in 1989, 1 paper(s) in 2002, 1 paper(s) in 2004, 6 paper(s) in 2006, 32 paper(s) in 2007, 12 paper(s) in 2008, for a total of 55 research publications in total.

Dennis W Dw Dickson Author Information

LAST NAME: dickson

FIRST NAME: Dennis W

INITIALS: dw

AFFILIATION:

Papers

Dennis W Dickson's Publication Record

1. Rates of cerebral atrophy differ in different degenerative pathologies. Year Published: 2007
Department of Radiology, Mayo Clinic Rochester, Rochester, MN 55905, USA.
2. Suppression of galactosylceramidase (GALC) expression in the twitcher mouse model of globoid cell leukodystrophy (GLD) is caused by nonsense-mediated mRNA decay (NMD). Year Published: 2006
Department of Pharmacology, Mayo Clinic College of Medicine, Jacksonville, FL 32224, USA.
3. beta-Amyloid Degradation and Alzheimer's Disease. Year Published: 2006
4. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons. Year Published: 2006
The Johnnie B. Byrd Sr. Alzheimer's Center and Research Institute Jacksonville, FL, USA. jpadmana@health.usf.edu
5. Frontotemporal dementia and parkinsonism associated with the IVS1+1G->A mutation in progranulin: a clinicopathologic study. Year Published: 2006
Department of Neurology, Mayo Clinic Rochester, MN 55905, USA. bboeve@mayo.edu
6. Heterogeneous inclusions in neurofilament inclusion disease. Year Published: 2006
Department of Neuroscience, Mayo Clinic, Jacksonville, Florida 32224, USA.
7. Frontotemporal lobar degeneration without lobar atrophy. Year Published: 2006
Department of Neurology, Division of Behavioral Neurology and Movement Disorders, Mayo Clinic, Rochester, MN 55905, USA. josephs.keith@mayo.edu
8. Linking selective vulnerability to cell death mechanisms in Parkinson's disease. Year Published: 2007
Department of Pathology, Mayo Clinic College of Medicine, Jacksonville, FL, USA. dickson.dennis@mayo.edu
9. Progranulin mutations in primary progressive aphasia: the PPA1 and PPA3 families. Year Published: 2007
Cognitive Neurology and Alzheimer's Disease Center and Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Ill 60611, USA. mmesulam@northwestern.edu
10. Insights into REM sleep behavior disorder pathophysiology in brainstem-predominant Lewy body disease. Year Published: 2007
Department of Neurology, Mayo Clinic College of Medicine, Rochester, MN, USA. bboeve@mayo.edu
11. Abeta40 inhibits amyloid deposition in vivo. Year Published: 2007
Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida 32224, USA.
12. Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions with progranulin gene (PGRN) mutations. Year Published: 2007
Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
13. Progranulin in frontotemporal lobar degeneration and neuroinflammation. Year Published: 2007
Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, FL, USA. ahmed.zeshan@mayo.edu <ahmed.zeshan@mayo.edu>
14. The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins. Year Published: 2007
Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA.
15. Voxel-based morphometry in frontotemporal lobar degeneration with ubiquitin-positive inclusions with and without progranulin mutations. Year Published: 2007
Division of Behavioral Neurology, Department of Neurology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA.
16. DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Year Published: 2007
Department of Neurology, Drexel University College of Medicine, Philadelphia, PA 19102, USA. clippa@drexelmed.edu
17. Identification of a novel risk locus for progressive supranuclear palsy by a pooled genomewide scan of 500,288 single-nucleotide polymorphisms. Year Published: 2007
Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, FL 32224, USA.
18. Progressive supranuclear palsy: pathology and genetics. Year Published: 2007
Department of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA. dickson.dennis@mayo.edu
19. Actin-binding proteins coronin-1a and IBA-1 are effective microglial markers for immunohistochemistry. Year Published: 2007
Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA.
20. TDP-43 in differential diagnosis of motor neuron disorders. Year Published: 2007
Department of Neuroscience, Mayo Clinic College of Medicine, 4500 San Pablo Road, Jacksonville, FL, 32224, USA. dickson.dennis@mayo.edu
21. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Year Published: 2007
Department of Neurology, Washington University School of Medicine, Campus Box 8118, 660 South Euclid Avenue, St Louis, MO, 63110, USA.
22. Quantitative PCR-based screening of alpha-synuclein multiplication in multiple system atrophy. Year Published: 2007
Department of Neuroscience, Molecular Genetics Laboratory and Core, Morris K. Udall Parkinson's Disease Research Center of Excellence, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, USA.
23. A novel locus for dementia with Lewy bodies: a clinically and genetically heterogeneous disorder. Year Published: 2007
Neurodegenerative Brain Diseases Group, Department of Molecular Genetics, VIB, Institute Born-Bunge, Antwerpen, Belgium.
24. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Year Published: 2007
Department of Neurology, Behavioral Neurology and Movement Disorders Unit, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey. muratemre@superonline.com
25. Hippocampal sclerosis in tau-negative frontotemporal lobar degeneration. Year Published: 2007
Department of Neurology, Behavioral Neurology & Movement Disorders, Mayo Clinic, Rochester, MN 5590, United States. josephs.keith@mayo.edu
26. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Year Published: 2007
Department of Neurology, 6Mayo Clinic College of Medicine, Rochester, MN 55905, USA. bboeve@mayo.edu
27. Frontotemporal lobar degeneration with upper motor neuron disease/ primary lateral sclerosis. Year Published: 2007
Divisions of Neurology, Mayo Clinic, Rochester, MN 55905, USA. jospehs.keith@mayo.edu
28. Clinical features of pathologic subtypes of behavioral--variant frontotemporal dementia. Year Published: 2007
Department of Neurology, Mayo Clinic College of Medicine, Rochester MN, USA.
29. Vascular dementia: clinical, neuroradiologic and neuropathologic aspects. Year Published: 2007
Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA dickson.dennis@mayo.edu.
30. Quantitative PCR-based screening of alpha-synuclein multiplication in multiple system atrophy. Year Published: 2007
Department of Neuroscience, Molecular Genetics Laboratory and Core, Morris K. Udall Parkinson's Disease Research Center of Excellence, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, USA.
31. TDP-43 immunoreactivity in neurodegenerative disorders: disease versus mechanism specificity. Year Published: 2007
Department of Neuroscience, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL, 32224, USA, dickson.dennis@mayo.edu.
32. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Year Published: 2007
Department of Neurology, 6Mayo Clinic College of Medicine, Rochester, MN 55905, USA. bboeve@mayo.edu
33. A study of infantile motor neuron disease with neurofilament and ubiquitin immunocytochemistry. Year Published: 1989
Department of Pathology (Neuropathology), Albert Einstein College of Medicine, Bronx, New York 10461.
34. Clinical features and survival of 3R and 4R tauopathies presenting as behavioral variant frontotemporal dementia. Year Published: 2007
Department of Neurology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
35. Progressive aphasia secondary to Alzheimer disease vs FTLD pathology. Year Published: 2008
Department of Neurology, Mayo Clinic, Rochester, MN 55905 josephs.keith@mayo.edu.
36. Progressive aphasia secondary to Alzheimer disease vs FTLD pathology. Year Published: 2008
Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA. josephs.keith@mayo.edu
37. Voxel-based morphometry in autopsy proven PSP and CBD. Year Published: 2008
Department of Neurology (Movement Disorders), Mayo Clinic, Rochester, MN 55905, USA. josephs.keith@mayo.edu
38. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Year Published: 2007
Department of Neurology, Behavioral Neurology and Movement Disorders Unit, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey. muratemre@superonline.com
39. Neurodegeneration involving putative respiratory neurons in Perry syndrome. Year Published: 2008
Department of Neurology, Fukuoka University, 7-45-1 Nanakuma, Johnan-ku, Fukuoka, 814-0180, Japan, tsuboi@cis.fukuoka-u.ac.jp.
40. Rates of brain atrophy over time in autopsy-proven frontotemporal dementia and Alzheimer disease. Year Published: 2008
Department of Radiology, Mayo Clinic, Rochester, MN, USA.
41. A study of infantile motor neuron disease with neurofilament and ubiquitin immunocytochemistry. Year Published: 1989
Department of Pathology (Neuropathology), Albert Einstein College of Medicine, Bronx, New York 10461.
42. Clinical features and survival of 3R and 4R tauopathies presenting as behavioral variant frontotemporal dementia. Year Published: 2007
Department of Neurology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
43. Clinical features and survival of 3R and 4R tauopathies presenting as behavioral variant frontotemporal dementia. Year Published: 2007
Department of Neurology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
44. Clinical features of pathologic subtypes of behavioral--variant frontotemporal dementia. Year Published: 2007
Department of Neurology, Mayo Clinic College of Medicine, Rochester MN, USA.
45. MR imaging of brainstem atrophy in progressive supranuclear palsy. Year Published: 2008
Dept. of Neurology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL, 32224, United States, wszolek.zbigniew@mayo.edu.
46. Clinical and neuropathologic features of progressive supranuclear palsy with severe pallido-nigro-luysial degeneration and axonal dystrophy. Year Published: 2008
Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, FL, USA.
47. Progressive aphasia secondary to Alzheimer disease vs FTLD pathology. Year Published: 2008
Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA. josephs.keith@mayo.edu
48. Gliomatosis cerebri presenting with hydrocephalus and dementia. Year Published: 1988
Department of Pathology (Neuropathology), Albert Einstein College of Medicine, Bronx, NY.
49. Voxel-based morphometry in autopsy proven PSP and CBD. Year Published: 2008
Department of Neurology (Movement Disorders), Mayo Clinic, Rochester, MN 55905, USA. josephs.keith@mayo.edu
50. Vascular dementia: clinical, neuroradiologic and neuropathologic aspects. Year Published: 2007
Department of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA.
51. Corticobasal degeneration and frontotemporal dementia presentations in a kindred with nonspecific histopathology. Year Published: 2002
Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA. bboeve@mayo.edu
52. Hippocampal sclerosis and ubiquitin-positive inclusions in dementia lacking distinctive histopathology. Year Published: 2004
Department of Neurology, Mayo Clinic, Rochester, Minn, USA.
53. Rates of brain atrophy over time in autopsy-proven frontotemporal dementia and Alzheimer disease. Year Published: 2008
Department of Radiology, Mayo Clinic, Rochester, MN 55905, USA.
54. Expanded-polyglutamine huntingtin protein suppresses the secretion and production of a chemokine (CCL5/RANTES) by astrocytes. Year Published: 2008
Graduate Institute of Life Sciences, National Defense Medical Center, Taipei 104, Taiwan.
55. Beta-amyloid burden is not associated with rates of brain atrophy. Year Published: 2008
Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA. josephs.keith@mayo.edu